RTI Biologics (RTIX)

RTI Biologics (RTIX)stem cell stocks

RTI Biologics, Inc.
11621 Research Circle
Alachua, FL 32615
United States - Map
Phone: 386-418-8888
Fax: 386-418-0342
Web Site: http://www.rtix.com
RTI Biologics, Inc., together with its subsidiaries, produces orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues, and improve surgical outcomes. The company processes human musculoskeletal and other tissues, including bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera and dermal tissues, and bovine animal tissues to produce allografts for hospitals and surgeons. It processes and distributes human and bovine animal tissues for spine, sports medicine, dental, surgical specialties, bone graft substitutes, and general orthopedic markets in the United States and internationally. The company was founded in 1997 and is headquartered in Alachua, Florida.


DiggDigg   | RedditReddit   | Add to Mixx!MixxDeldel.icio.usStumble Stumble it!Bookmark and Share Share it


More articles Cell Therapeutics, Inc

More articles Stem Cell Companies

More articles Stem Cell Stocks

More articles BioMimetic Therapeutics (BMTI)

More articles Pluristem Therapeutics-PTSI

More articles Osiris Therapeutics-OSIR

More articles Cytori Therapeutics, Inc.

More articles ThermoGenesis (KOOL)

More articles Nutra Pharma (OTCBB:NPHC)

More articles Human Embryonic Stem Cell Market

More articles RTI Biologics (RTIX)

More articles Aastrom Biosciences -ASTM



XOMA 052 Designated Orphan Drug by FDA ...
Published:Wed, 04 Aug 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Food and Drug Administration has designated XOMA 052, ......
XOMA to Announce 2010 Second Quarter Fi...
Published:Mon, 02 Aug 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of antibody therapeutics, announced that the company will host a webcast conference call on Monday, Augus......
XOMA 052 Orphan Drug Designation for Be...
Published:Thu, 29 Jul 2010 05:00:00 -0700
BERKELEY, Calif. -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, announced that the Committee for Orphan Medical Products of the European Medic......
Biotech Stocks: Depomed, Dendreon lead ...
Published:Wed, 04 Aug 2010 07:55:59 -0700
Depomed lead gains among drug stocks a day after it said Pfizer will not file a patent infringement lawsuit to prevent the launch of a painkiller.......
Trader Favorite Dendreon Spikes On Prov...
Published:Wed, 04 Aug 2010 08:00:00 -0700
After soaring higher on the FDA approval of its Provenge prostate cancer vaccine in April, volatile Dendreon quickly retreated to well below its pre-approval pricing, but sales fi......
© 2010 | Privacy Policy | Powered By Noomle.com | SiteMap